Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Virginia Nguyen

Surgery Norfolk, VA Medical Doctor

NPI 1821470998 CMS profile 1331848

600 Gresham Dr, Ste 301, Norfolk, VA 23507

Open in the dashboard

General payments

$20,927

147 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Virginia Nguyen of Norfolk, VA is reported in the CMS Open Payments database as having received $20,927 across 147 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,172 21
2024 General $6,569 19
2023 General $2,803 46
2022 General $3,399 36
2021 General $6,970 24
2020 General $14 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Virginia Nguyen
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Virginia Nguyen were reported at $1,172. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Virginia Nguyen Surgery median Middle half National median
2019 $0 $253 $82–$1,521 $163
2020 $14 $131 $40–$706 $114
2021 $6,970 $168 $50–$904 $132
2022 $3,399 $224 $76–$1,218 $149
2023 $2,803 $253 $82–$1,255 $160
2024 $6,569 $279 $90–$1,381 $164
2025 $1,172 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medtronic, Inc. $15,507 70 payments
  2. W. L. Gore & Associates, Inc. $2,306 17 payments
  3. Penumbra, Inc. $509 4 payments
  4. Inari Medical, Inc. $477 22 payments
  5. Abbott Laboratories $455 5 payments
  6. Shockwave Medical, Inc $412 4 payments
  7. Philips Electronics North America Corporation $327 5 payments
  8. Bolton Medical Inc $316 4 payments
  9. Silk Road Medical, Inc. $288 7 payments
  10. Maquet Cardiovascular U.S. Sales, L.L.C. $170 3 payments
  11. Other $160 6 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $8,791 131 payments
  2. Travel and Lodging $7,262 13 payments
  3. Grant $4,375 1 payment
  4. Education $499 2 payments
Products named General payments · program years 2020–2025
  1. HawkOne $5,896 7 payments
  2. Endurant $4,746 8 payments
  3. ENDURANT IIS $2,716 28 payments
  4. GORE TAG Thoracic Endoprosthesis $906 4 payments
  5. Valiant Captivia $581 5 payments
  6. EXCLUDER Conformable AAA Endoprosthesis with Active Control $516 5 payments
  7. CT THROMBECTOMY SYSTEM KIT $477 22 payments
  8. FLOWTRIEVER CATHETER, S $477 22 payments
  9. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $412 4 payments
  10. GORE EXCLUDER AAA Endoprosthesis $409 3 payments
  11. Other $3,351 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

90

Median for Vascular Surgery: 122

Drug cost

$19,730

Median for Vascular Surgery: $14,135

Branded share of claims

58.9%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 23 $18,900
Clopidogrel Clopidogrel Bisulfate Brand 30 $488
Cilostazol Generic 13 $265
Oxycodone Hcl Generic 24 $77

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$68,642

Medicare's payments for the services billed

Medicare patients

336

Average age 74

Services billed

630

143 women, 193 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 41%
Ischemic heart disease 39%
Chronic kidney disease 38%
Arthritis 38%
Heart failure 31%
Depression 24%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

147 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record